Lindsey Layden, PA-C | |
1200 N Elm St, Greensboro, NC 27401-1004 | |
(336) 716-2255 | |
Not Available |
Full Name | Lindsey Layden |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 1200 N Elm St, Greensboro, North Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346758075 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 0010-07815 (North Carolina) | Secondary |
363A00000X | Physician Assistant | 0010-07815 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lindsey Layden, PA-C Po Box 344, Winston Salem, NC 27102-0344 Ph: (336) 716-2255 | Lindsey Layden, PA-C 1200 N Elm St, Greensboro, NC 27401-1004 Ph: (336) 716-2255 |
News Archive
With cancer's incidence and treatment costs rising, HealthHelp has become the first company to provide radiation oncology management on a national scale. Approximately 4 million Humana patients in 46 states will benefit from this innovative new program.
Clearstone Central Laboratories, a leading global provider of clinical laboratory and centralized cardiac services for clinical trials, today announced the expansion of testing capabilities at its Toronto laboratory. Additional safety as well as esoteric testing capacity and capabilities will be added to the existing operations.
Discussions about end of life practices in Germany have been almost taboo for over half a century, but now intense debate is underway as professional bodies review their guidelines to physicians caring for the dying. A new study out today in Palliative Medicine, published by SAGE, reveals that German physicians do hasten death in some cases, against current ethical guidelines - sometimes without sufficient patient involvement.
New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest it could be useful for enhancing protection against a number of different infections.
"The incidence of type l diabetes, one of the most prevalent chronic diseases in children, has increased worldwide," write Valma Harjutsalo, Ph.D., of the Diabetes Prevention Unit, Helsinki, Finland, and colleagues, who conducted a study to examine the incidence rates of T1D between 2006 and 2011 in Finnish children younger than 15 years as well as the 32-year trend (1980-2011).
› Verified 3 days ago